{"id":"https://openalex.org/W1978188077","doi":"https://doi.org/10.1055/s-2007-1017025","title":"KC 9172* (Free Base of KC 7218) - An Antipsychotic/Anxiolytic Compound II. Discrimiantion from Typical Neuroleptics and Benzodiazepine-like Minor Tranquilizers","display_name":"KC 9172* (Free Base of KC 7218) - An Antipsychotic/Anxiolytic Compound II. Discrimiantion from Typical Neuroleptics and Benzodiazepine-like Minor Tranquilizers","publication_year":1988,"publication_date":"1988-11-01","ids":{"openalex":"https://openalex.org/W1978188077","doi":"https://doi.org/10.1055/s-2007-1017025","mag":"1978188077","pmid":"https://pubmed.ncbi.nlm.nih.gov/2907650"},"language":"en","primary_location":{"id":"doi:10.1055/s-2007-1017025","doi":"https://doi.org/10.1055/s-2007-1017025","is_oa":false,"landing_page_url":"https://doi.org/10.1055/s-2007-1017025","pdf_url":null,"source":{"id":"https://openalex.org/S4122505","display_name":"Pharmacopsychiatry","issn_l":"0176-3679","issn":["0176-3679","1439-0795"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","medline","norway-1","poland-70","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320000","host_organization_name":"Thieme Medical Publishers (Germany)","host_organization_lineage":["https://openalex.org/P4310320000"],"host_organization_lineage_names":["Thieme Medical Publishers (Germany)"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmacopsychiatry","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":null,"display_name":"H. Kr\u00e4hling","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"H. Kr\u00e4hling","raw_affiliation_strings":["Kali-Chemie AG, Pharmaceutical Division, Department of Pharmacology, Hannover, FRG","Department of Pharmacology, Kali-Chemie AG, Pharmaceutical Division"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Kali-Chemie AG, Pharmaceutical Division, Department of Pharmacology, Hannover, FRG","institution_ids":[]},{"raw_affiliation_string":"Department of Pharmacology, Kali-Chemie AG, Pharmaceutical Division","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079616133","display_name":"Andreas Fuchs","orcid":"https://orcid.org/0000-0002-7230-4121","observed_orcids":["https://orcid.org/0000-0002-7230-4121"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"A. Fuchs","raw_affiliation_strings":["Department of Pharmacology, Kali-Chemie AG, Pharmaceutical Division"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacology, Kali-Chemie AG, Pharmaceutical Division","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5031334409","display_name":"Michael Ruhland","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"M. Ruhland","raw_affiliation_strings":["Department of Pharmacology, Kali-Chemie AG, Pharmaceutical Division"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacology, Kali-Chemie AG, Pharmaceutical Division","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5091518518","display_name":"Uwe Sch\u00f6n","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"U. Sch\u00f6n","raw_affiliation_strings":["Department of Chemistry, Hannover, FRG"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Chemistry, Hannover, FRG","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090713786","display_name":"F. Mol","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"F. Mol","raw_affiliation_strings":["Duphar B. V., Department of Pharmacology, Weesp, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Duphar B. V., Department of Pharmacology, Weesp, The Netherlands","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5113731624","display_name":"Martin Th. M. Tulp","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"M. Tulp","raw_affiliation_strings":["Duphar B. V., Department of Pharmacology, Weesp, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Duphar B. V., Department of Pharmacology, Weesp, The Netherlands","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":1.2756,"has_fulltext":false,"cited_by_count":9,"citation_normalized_percentile":{"value":0.79278937,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":93},"biblio":{"volume":"21","issue":"06","first_page":"399","last_page":"401"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":0.9101999998092651,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":0.9101999998092651,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":0.06019999831914902,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10077","display_name":"Neuroscience and Neuropharmacology Research","score":0.006000000052154064,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/free-base","display_name":"free base","score":0.7229999899864197},{"id":"https://openalex.org/keywords/antipsychotic-drugs","display_name":"antipsychotic drugs","score":0.7570000290870667},{"id":"https://openalex.org/keywords/anxiolytics","display_name":"anxiolytics","score":0.9980000257492065},{"id":"https://openalex.org/keywords/typical-antipsychotics","display_name":"typical antipsychotics","score":0.9649999737739563},{"id":"https://openalex.org/keywords/drug-discrimination","display_name":"drug discrimination","score":0.5339999794960022}],"concepts":[{"id":"https://openalex.org/C2777765862","wikidata":"https://www.wikidata.org/wiki/Q62903","display_name":"Anxiolytic","level":3,"score":0.8264050483703613},{"id":"https://openalex.org/C2778173252","wikidata":"https://www.wikidata.org/wiki/Q83871","display_name":"Benzodiazepine","level":3,"score":0.6195090413093567},{"id":"https://openalex.org/C2780494398","wikidata":"https://www.wikidata.org/wiki/Q208144","display_name":"Antipsychotic","level":3,"score":0.5540724992752075},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.36819514632225037},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.358987033367157},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.34783321619033813},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.2697315216064453},{"id":"https://openalex.org/C558461103","wikidata":"https://www.wikidata.org/wiki/Q154430","display_name":"Anxiety","level":2,"score":0.1633794605731964},{"id":"https://openalex.org/C2776412080","wikidata":"https://www.wikidata.org/wiki/Q7431605","display_name":"Schizophrenia (object-oriented programming)","level":2,"score":0.14467638731002808},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.07374262809753418},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.03466379642486572}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001362","descriptor_name":"Avoidance Learning","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D001643","descriptor_name":"Bridged Bicyclo Compounds","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D001952","descriptor_name":"Bridged-Ring Compounds","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D002065","descriptor_name":"Buspirone","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D002746","descriptor_name":"Chlorpromazine","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D003024","descriptor_name":"Clozapine","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D003220","descriptor_name":"Conflict, Psychological","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003975","descriptor_name":"Diazepam","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D011919","descriptor_name":"Rats, Inbred Strains","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011985","descriptor_name":"Receptors, Serotonin","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D014150","descriptor_name":"Antipsychotic Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D014151","descriptor_name":"Anti-Anxiety Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D019086","descriptor_name":"Bridged Bicyclo Compounds, Heterocyclic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D051381","descriptor_name":"Rats","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1055/s-2007-1017025","doi":"https://doi.org/10.1055/s-2007-1017025","is_oa":false,"landing_page_url":"https://doi.org/10.1055/s-2007-1017025","pdf_url":null,"source":{"id":"https://openalex.org/S4122505","display_name":"Pharmacopsychiatry","issn_l":"0176-3679","issn":["0176-3679","1439-0795"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","medline","norway-1","poland-70","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320000","host_organization_name":"Thieme Medical Publishers (Germany)","host_organization_lineage":["https://openalex.org/P4310320000"],"host_organization_lineage_names":["Thieme Medical Publishers (Germany)"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmacopsychiatry","raw_type":"journal-article"},{"id":"pmid:2907650","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/2907650","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmacopsychiatry","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.6240000128746033}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2087901644","https://openalex.org/W2409157857","https://openalex.org/W2335639983","https://openalex.org/W2952647192","https://openalex.org/W2004868507","https://openalex.org/W2419202932","https://openalex.org/W2415680795","https://openalex.org/W2180447747","https://openalex.org/W4406056443","https://openalex.org/W2410302582"],"abstract_inverted_index":null,"counts_by_year":[{"year":2016,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}